Pemafibrate Confers Some Renal Benefits for Patients With CKD and Obesity

The risk of progression to chronic kidney disease (CKD) is heightened for patients with elevated serum triglyceride (TG) levels. However, few data are available regarding whether lowering levels of serum TG confers renoprotective benefits. Mai…

Continue Reading